Inactivation of CYP2D6 by Berberrubine and the Chemical Mechanism
Biochemistry · 2024
DOI: 10.1021/acs.biochem.4c00450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, 2024. Verfasst von Jinqiu Rao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P. R. China. Hauptthemen laut MEDLINE: Berberine, Cytochrome P-450 CYP2D6. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Tianjin Municipal Enterprise Technology Commissioner Project, Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Berberrubine (BRB), belonging to the benzylisoquinoline alkaloid, is a main metabolite of berberine in vivo. BRB was previously proven to undergo metabolic activation mediated by P450s. In this study, the chemical interactions between BRB and CYP2D6 enzyme were investigated. First, a variety of P450s participated in the metabolism of berberine transformed to BRB, but CYP2D6 was the most involved enzyme. A time-, concentration-, and nicotinamide adenine dinucleotide phosphate (NADPH)-dependent inhibition of CYP2D6 was caused by BRB. The inhibitory effect of BRB on CYP2D6 was irreversible. The maximum reaction rate constants of inactivation (kinact) and half-maximal inactivation (KI) of BRB on CYP2D6 were 0.0410 min-1 and 3.798 μM, respectively. Metoprolol, a classic substrate of CYP2D6, attenuated CYP2D6 from inactivation by BRB. Glutathione (GSH) and catalase/superoxide dismutase failed to protect against the inactivation of CYP2D6 caused by BRB. Three cys-based adducts derived from the reaction of electrophilic metabolites of BRB with CYP2D6 were detected by ultra performance liquid chromatography-mass spectrometry (UPLC-MS)/MS. The reactive metabolites derived from BRB might be responsible for the inactivation of CYP2D6. In summary, BRB was characterized as a mechanism-based inactivator of CYP2D6.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P. R. China.
- Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P. R. China.
- State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P. R. China.
Förderung
- Tianjin Municipal Enterprise Technology Commissioner Project
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
- National University Student Innovation and Entrepreneurship Development Program of China
Zitieren
APA
Rao, J., Wang, T., Yu, L., Wang, K., & Qiu, F. (2024). Inactivation of CYP2D6 by Berberrubine and the Chemical Mechanism. Biochemistry. https://doi.org/10.1021/acs.biochem.4c00450
Vancouver
Rao J, Wang T, Yu L, Wang K, Qiu F. Inactivation of CYP2D6 by Berberrubine and the Chemical Mechanism. Biochemistry. 2024. doi:10.1021/acs.biochem.4c00450
BibTeX
@article{Rao2024,
author = {Rao, Jinqiu and Wang, Tianwang and Yu, Leran and Wang, Kai and Qiu, Feng},
title = {Inactivation of CYP2D6 by Berberrubine and the Chemical Mechanism},
journal = {Biochemistry},
year = {2024},
doi = {10.1021/acs.biochem.4c00450}
}
EUVIMED